Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL110305 | 1.00 | GAA (0.47) | GAAATML3MBTL1POLBMEN1 | |
| SCHEMBL8791153 | 0.91 | GAA (0.51) | GAAATML3MBTL1POLBMEN1 | |
| SCHEMBL8791145 | 0.91 | GAA (0.51) | GAAATML3MBTL1POLBMEN1 | |
| SCHEMBL4275570 | 0.91 | GAA (0.51) | GAAATML3MBTL1POLBMEN1 | |
| SCHEMBL9124935 | 0.88 | GAA (0.44) | GAAATML3MBTL1 | |
| SCHEMBL9124932 | 0.88 | GAA (0.44) | GAAATML3MBTL1 | |
| SCHEMBL27290975 | 0.84 | GAA (0.50) | GAAATML3MBTL1POLB | |
| SCHEMBL13588265 | 0.81 | GAA (0.34) | GAA | |
| SCHEMBL13588319 | 0.80 | GAA (0.43) | GAAATML3MBTL1KMT2A | |
| SCHEMBL225193 | 0.80 | GAA (0.49) | GAAATML3MBTL1POLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 450 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7271213-B2 | Pigment dispersing resin | KANSAI PAINT CO., LTD. (JP) | 2007-09-18 | — | — | US | claimed |
| US-6994745-B2 | Pigment dispersing resin | KANSAI PAINT CO., LTD. (JP) | 2006-02-07 | — | — | US | claimed |
| US-20050252418-A1 | Copolymer of an unsaturated monomer containing an ionic functional groups such as, tert-amino, quaternary ammonium salt and sulfonic acid; an polyethoxylated acrylate, ultraviolet absorbing unsaturated monomer and other | HOSHIDA YUKO | 2005-11-17 | — | — | US | claimed |
| EP-1118632-B1 | Composite particles, composite particle dispersion composition, and method of preparing composite particle dispersion composition | JSR CORP (JP) | 2005-04-13 | — | — | EP | claimed |
| US-6541114-B2 | Composite particles, composite particle dispersion composition, and method of preparing composite particle dispersion composition | JSR CORPORATION (JP) | 2003-04-01 | — | — | US | claimed |
| US-20030045637-A1 | Pigment dispersing resin | KANSAI PAINT CO., LTD. (JP) | 2003-03-06 | — | — | US | claimed |
| EP-1247821-A2 | Pigment dispersing resin | KANSAI PAINT CO., LTD. (JP) | 2002-10-09 | — | — | EP | claimed |
| US-20010033932-A1 | Composite particles, composite particle dispersion composition, and method of preparing composite particle dispersion composition | JSR CORPORATION (JP) | 2001-10-25 | — | — | US | claimed |
| EP-1118632-A2 | Composite particles, composite particle dispersion composition, and method of preparing composite particle dispersion composition | JSR Corporation (JP) | 2001-07-25 | — | — | EP | claimed |
| US-12637574-B2 | Coating composition | KANSAI PAINT CO., LTD. (JP) | 2026-05-26 | — | — | US | disclosed |
| US-12630654-B2 | Emulsion particle-containing aqueous dispersion | NIPPON SHOKUBAI CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12629926-B2 | Decorative sheet and decorative material | DAI NIPPON PRINTING CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12590214-B2 | Ink-jet ink | NIPPON SHOKUBAI CO., LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| US-12576431-B2 | Method for forming multi-layer coating film | KANSAI PAINT CO., LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| EP-0337744-A2 | Ultraviolet-stable copolymer. Process for producing the same, and coating composition containing the same | NIPPON SHOKUBAI CO., LTD. (JP) | 1989-10-18 | — | — | EP | disclosed |
| EP-0208263-B1 | Process for the preparation of 1-oxa-3,8-diaza-4-spiro[4,5]decane compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-09-06 | — | — | EP | disclosed |
| EP-0293871-A2 | Light stabilized, starshaped microparticles | CIBA-GEIGY AG (CH) | 1988-12-07 | — | — | EP | disclosed |
| US-4745192-A | 1-oxa-3-oxo-4,8-diaza-spiro(4,5)decane compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-05-17 | — | — | US | disclosed |
| US-4689416-A | PHASE TRANSFER CATALYST | HOECHST AKTIENGELLSCHAFT (DE) | 1987-08-25 | — | — | US | disclosed |
| EP-0208263-A1 | Process for the preparation of 1-oxa-3,8-diaza-4-spiro[4,5]decane compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629926-B2 | Decorative sheet and decorative material | TLL1, POT1, TLL2 | GAA 3322/4885ATM 1237/4885L3MBTL1 424/4885 |
| US-12637574-B2 | Coating composition | ITGB3, ATG13, C9 | GAA 1753/4885ATM 1537/4885L3MBTL1 830/4885 |
| US-12630654-B2 | Emulsion particle-containing aqueous dispersion | CLTB, CLTA, APOB | GAA 3443/4885ATM 2245/4885L3MBTL1 372/4885 |
| US-12576431-B2 | Method for forming multi-layer coating film | SPIN3, SLC6A3, MARK3 | GAA 3991/4885ATM 4628/4885L3MBTL1 293/4885 |
| US-12590214-B2 | Ink-jet ink | MIF, ELANE, SEM1 | GAA 4658/4885ATM 1041/4885L3MBTL1 1552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.